The U.S. Court of Appeals for the First Circuit recently provided important clarity—and welcome relief—for clinical laboratories facing False Claims Act (“FCA”) allegations based on a lack of medical ...
Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most ...
Anesthesia teams are under pressure as surgical demand rises, staffing tightens and financial strains mount. Yet the specialty is entering a pivotal year of change, and the decisions made now will ...
The US Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target action date for Aldeyra’s New Drug Application (NDA) for reproxalap for the treatment of dry ...
Everyday Health on MSN
MASH: Is semaglutide right for you?
Learn about semaglutide’s effectiveness and clinical trial results and whether it could be right for you in your MASH ...
A personalized alert tool improve use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for ...
Eustachian tube dysfunction (ETD) is associated with shorter disease duration and more severe aural fullness symptoms, ...
Additionally, in 2025, the U.S. Food and Drug Administration (FDA) approved 11 drugs based on clinical trials in which MSK played a pivotal role. “MSK’s clinical research teams made great progress in ...
School will help shape life-changing health care policies, technologies, and research that close the health care gap ...
Dr. Sreedhar Somisetty will join the provider team at Van Diest Medical Center beginning in January. Dr. Somisetty is a ...
West Des Moines, Iowa – December 11, 2025 – PRESSADVANTAGE – In Modern Vision Center’s new article, Dr. Drew Dickson: Des ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback